Environmental & Healthcare Legislative Watch50 States · D.C. · U.S. Congress
From official state and federal legislative records. Informational only, not legal advice.
Halfway — passed one chamber
One of the two groups of lawmakers voted yes. Now the other group gets to vote.
Next: the other chamber takes it up — committee first, then a vote.
In plain words
AI summaryWritten by AI from the bill text. Check the official text before relying on it.
The purpose of this bill is to establish a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the Administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
